Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maria Gabriella Jannuzzo"'
Autor:
Maurizio Rocchetti, Italo Poggesi, Marta Valle, Davide Verotta, Maria Gabriella Jannuzzo, Riccardo Spinelli, Enrico Di Salle
Publikováno v:
British Journal of Clinical Pharmacology. 59:355-364
Aims Exemestane (Aromasin®) is an irreversible aromatase inactivator used for the treatment of postmenopausal women with advanced breast cancer. The objective of this study was to evaluate the effect of formulation comparing a sugar-coated tablet (S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fa3da292e77c2c4e033988747226545
https://doi.org/10.1111/j.1365-2125.2005.02335.x
https://doi.org/10.1111/j.1365-2125.2005.02335.x
Autor:
Nicoletta Pirotta, Akintunde Bello, Riccardo Spinelli, Peter Buchan, Maria Gabriella Jannuzzo, Enrico Di Salle
Publikováno v:
Breast cancer research and treatment. 113(3)
Introduction Luteinizing hormone-releasing hormone (LHRH) agonists (e.g., triptorelin) reduce ovarian estrogen production in premenopausal women with hormone-sensitive breast cancer. Aromatase inhibitors (e.g., exemestane) inhibit extraovarian produc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9c406d8f3f60a19cf50f01c1641665f
https://pubmed.ncbi.nlm.nih.gov/18330698
https://pubmed.ncbi.nlm.nih.gov/18330698
Autor:
Maurizio Rocchetti, Paolo Cicioni, Maria Gabriella Jannuzzo, Italo Poggesi, Peter Buchan, Riccardo Spinelli
Publikováno v:
Cancer chemotherapy and pharmacology. 53(6)
Two studies were conducted to compare the pharmacokinetics and tolerability of exemestane in postmenopausal subjects with various degrees of impairment of hepatic or renal function with those in healthy postmenopausal subjects. All subjects were post
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c024b4d05bdf6881a925f4f0ebcc9c44
https://pubmed.ncbi.nlm.nih.gov/15014897
https://pubmed.ncbi.nlm.nih.gov/15014897
Autor:
E. Di Salle, N. Pirotta, Peter Buchan, Giorgio Massimini, Riccardo Spinelli, Maria Gabriella Jannuzzo
Publikováno v:
Journal of Clinical Oncology. 22:2041-2041
2041 Background: Gonadotrophin-releasing hormone agonists (Gn-RHa), such as triptorelin (T), reduce the ovarian estrogen production in premenopausal women, thus inducing a reversible postmenopausal...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::709d801c2da7ff6e5a77993e57703a70
https://doi.org/10.1200/jco.2004.22.90140.2041
https://doi.org/10.1200/jco.2004.22.90140.2041